Alzheimer’s disease stands as the most widespread form of dementia globally, increasingly burdening families, healthcare ...

ABC News' Dr. Tara Narula breaks down a new study suggesting that a common HIV medication may significantly reduce the risk ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's ...

Seven-Market Drug Forecast,” reveals that market growth will primarily be driven by the increased uptake of long-acting ...

People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA ...

NEW YORK (Reuters) -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the ...

In the face of a fear of loss of funds for ending the HIV/AIDS epidemic, activists in New Jersey walked to raise money.